Search - tctmd.com

Displaying 181 - 200 of 254

Sort: Relevancy | Date

News Conference News

Drug-Eluting Balloons an Option for Patients with BMS Restenosis, High Bleeding Risk

November 17, 2011

News Industry News

REMEDEE Study Meets Primary Endpoint: OrbusNeich’s Combo™ Dual Therapy Stent Is Non-Inferior to DES

November 13, 2011

News Conference News

Two New SES Show Improvement Over First-Generation Stents

Yael L. Maxwell

November 10, 2011

News Industry News

Rotablation does not improve efficacy of drug-eluting stents in complex calcified coronary lesions

November 10, 2011

News Industry News

Polymer-free drug eluting stents result in lower in-stent late loss

November 10, 2011

News Industry News

Paclitaxel-coated balloon angioplasty demonstrates superior results

November 10, 2011

News Conference News

PARIS: Early DAPT Nonadherence, A Small Problem with Big Consequences

November 09, 2011

News Industry News

Bayer HealthCare's Cotavance Drug Eluting Balloon With Paccocath Technology Reduced Five-Year Target Lesion Revascularization Rates

November 09, 2011

News Conference News

Preclinical Results Promising for Combo Stent

November 08, 2011

News Conference News

Polymer-free DES Shown Effective in Multiple Trials

November 08, 2011

News Conference News

ZES, EES Noninferior to PES

November 07, 2011

News Conference News

ZES Match or Exceed Performance of Earlier DES

November 07, 2011

News Conference News

PAX Studies Highlight Polymer-Free DES Success

November 07, 2011

News Conference News

Efficacy of SES for In-stent Restenosis Dependent on Original Stent Type

November 07, 2011

News Conference News

DES and Stent Thrombosis Revisited

November 07, 2011

News Industry News

Boston Scientific Platinum Chromium ION™ Stent Demonstrates Positive Outcomes in PERSEUS Clinical Program

November 07, 2011

News Conference News

Evidence of Late Catch-up After DES ‘Unequivocal’

November 06, 2011

News Conference News

Early Discontinuation of DAPT May Increase Risk of Stent Thrombosis

November 06, 2011

News Conference News

DES Noninferior for Survival Compared with BMS in STEMI

November 06, 2011

News Industry News

Medtronic’s Unmatched Portfolio of Cardiovascular Devices Features Prominently on Program for TCT 2011

November 04, 2011

Advertisement

Drug-Eluting Balloons an Option for Patients with BMS Restenosis, High Bleeding Risk

REMEDEE Study Meets Primary Endpoint: OrbusNeich’s Combo™ Dual Therapy Stent Is Non-Inferior to DES

Two New SES Show Improvement Over First-Generation Stents

Rotablation does not improve efficacy of drug-eluting stents in complex calcified coronary lesions

Polymer-free drug eluting stents result in lower in-stent late loss

Paclitaxel-coated balloon angioplasty demonstrates superior results

PARIS: Early DAPT Nonadherence, A Small Problem with Big Consequences

Bayer HealthCare's Cotavance Drug Eluting Balloon With Paccocath Technology Reduced Five-Year Target Lesion Revascularization Rates

Preclinical Results Promising for Combo Stent

Polymer-free DES Shown Effective in Multiple Trials

ZES, EES Noninferior to PES

ZES Match or Exceed Performance of Earlier DES

PAX Studies Highlight Polymer-Free DES Success

Efficacy of SES for In-stent Restenosis Dependent on Original Stent Type

DES and Stent Thrombosis Revisited

Boston Scientific Platinum Chromium ION™ Stent Demonstrates Positive Outcomes in PERSEUS Clinical Program

Evidence of Late Catch-up After DES ‘Unequivocal’

Early Discontinuation of DAPT May Increase Risk of Stent Thrombosis

DES Noninferior for Survival Compared with BMS in STEMI

Medtronic’s Unmatched Portfolio of Cardiovascular Devices Features Prominently on Program for TCT 2011

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content